Iqvia Holdings (IQV) Interest Coverage Ratio (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Interest Coverage Ratio came in at 2.57 in Q2 2026, down 7.61% year-over-year from 2.78 in Q2 2025, and down 4.05% quarter-over-quarter from 2.68 in Q1 2026.
Analysis
Iqvia Holdings (IQV) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Interest Coverage Ratio across 15 years of filings, most recently posting 2.57 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 7.61% year-over-year to 2.57; the TTM figure through Jun 2026 stood at 2.85 (down 9.86% YoY), while the FY2025 annual figure was 2.99, down 8.93% from the prior year.
- Interest Coverage Ratio came in at 2.57 for Q2 2026 at Iqvia Holdings, down from 2.68 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 5.76 in Q1 2022 to a low of 2.57 in Q2 2026.
- Average Interest Coverage Ratio over 5 years is 3.34, with a median of 3.07 recorded in 2024.
- The largest YoY upside for Interest Coverage Ratio was 66.62% in 2022 against a maximum downside of 42.44% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 2.96 in 2022, then decreased by 6.52% to 2.77 in 2023, then jumped by 32.26% to 3.66 in 2024, then dropped by 11.26% to 3.25 in 2025, then dropped by 20.94% to 2.57 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.57 in Q2 2026, 2.68 in Q1 2026, and 3.25 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.83 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 3.95 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -689.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.57 |
| Mar 31, 2026 | 2.68 |
| Dec 31, 2025 | 3.25 |
| Sep 30, 2025 | 2.93 |
| Jun 30, 2025 | 2.78 |
| Mar 31, 2025 | 3.01 |
| Dec 31, 2024 | 3.66 |
| Sep 30, 2024 | 3.24 |
| Jun 30, 2024 | 3.19 |
| Mar 31, 2024 | 3.05 |
| Dec 31, 2023 | 2.77 |
| Sep 30, 2023 | 2.66 |
| Jun 30, 2023 | 3.10 |
| Mar 31, 2023 | 3.34 |
| Dec 31, 2022 | 2.96 |
| Sep 30, 2022 | 4.37 |
| Jun 30, 2022 | 4.82 |
| Mar 31, 2022 | 5.76 |
| Dec 31, 2021 | 5.14 |
| Sep 30, 2021 | 3.28 |